
    
      The study is a double-blind randomized controlled clinical trial of approximately 118
      patients (males and females) who are at least 40 years of age, who are scheduled for Total
      Knee Arthroplasty (TKA) surgery will be randomized into 1) a treatment group who receive
      Kneehab XP and a standard rehabilitation program and 2) a control group who receive only a
      sham device and a standard rehabilitation program. Patients are tracked for measures of
      function, pain, quality of life, physical performance and acceptable states status at 6 weeks
      and 1 week before surgery and 3, 6, 12, and 52 weeks following surgery.
    
  